| |
| |
|
| Insider
Information: |
Smith Scott Andrew |
| Relationship: |
|
| City: |
Summit |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
462,519 |
|
|
Indirect Shares
|
2,788 |
|
|
| Direct
Value |
$6,556,499 |
|
|
|
Indirect Value
|
$301,773 |
|
|
| Total
Shares |
465,307 |
|
|
| Total
Value |
$6,858,272 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celgene Corp |
CELG |
See Remarks |
2018-02-17 |
49,419 |
2018-02-17 |
2,788 |
Premium* |
|
|
F-star Therapeutics, Inc |
FSTX |
Director |
2019-12-31 |
37,476 |
2019-03-29 |
0 |
Premium* |
|
|
Bioatla, Inc. |
BCAB |
|
2024-04-30 |
290,274 |
|
0 |
Premium* |
|
|
Upjohn Inc |
VTRS |
|
2024-03-03 |
85,350 |
2024-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CELG |
Celgene Corp |
See RemarksOfficer |
• – – |
2014-08-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,325 |
|
- |
|
| CELG |
Celgene Corp |
See RemarksOfficer |
• – – |
2014-08-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
3,858 |
|
- |
|
| BCAB |
Bioatla, Inc. |
PresidentOfficer |
• • – |
2020-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
353,000 |
|
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2014-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,670 |
6,670 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2015-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,666 |
22,510 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2015-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
29,433 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2015-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
29,248 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
36,656 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2016-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
35,419 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2016-12-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,400 |
39,875 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2017-07-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
45,415 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2017-12-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,410 |
46,233 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2018-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,283 |
51,748 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2019-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,883 |
1,883 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2019-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,352 |
19,235 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2019-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,741 |
24,976 |
0 |
- |
|
| FSTX |
F-star Therapeutics, Inc |
Director |
– • – |
2019-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
37,476 |
0 |
- |
|
| VTRS |
Upjohn Inc |
Chief Executive Officer |
• • – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
140,727 |
87,278 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-10-31 |
4 |
D |
$1.47 |
$2,633 |
D/D |
(1,791) |
302,580 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-09-30 |
4 |
D |
$1.70 |
$3,045 |
D/D |
(1,791) |
304,371 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-11-30 |
4 |
D |
$1.77 |
$3,170 |
D/D |
(1,791) |
300,789 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2024-01-31 |
4 |
D |
$1.92 |
$4,188 |
D/D |
(2,181) |
296,817 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
|
– • – |
2024-04-30 |
4 |
D |
$2.26 |
$4,929 |
D/D |
(2,181) |
290,274 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
President |
• • – |
2022-05-31 |
4 |
D |
$2.41 |
$4,316 |
D/D |
(1,791) |
333,417 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-12-31 |
4 |
D |
$2.46 |
$4,406 |
D/D |
(1,791) |
298,998 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
